Authors:
Weber, O
Bender, W
Eckenberg, P
Goldmann, S
Haerter, M
Hallenberger, S
Henninger, K
Reefschlager, J
Trappe, J
Witt-Laido, A
Ruebsamen-Waigmann, H
Citation: O. Weber et al., Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo, ANTIVIR RES, 49(3), 2001, pp. 179-189
Authors:
Ottinger, HD
Muller, C
Schmitz, N
Kubanek, B
Arnold, R
Ebell, W
Eberhard, HP
Ehninger, G
Fronz, U
Goldmann, S
Grosse-Wilde, H
Havers, W
Klingebiel, T
Kolb, HJ
Seeber, S
Schaefer, UW
Baldomero, H
Gratwohl, A
Citation: Hd. Ottinger et al., Transplant activities in Germany in 1998 - a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation, ANN HEMATOL, 79(8), 2000, pp. 437-443
Citation: S. Goldmann, Friedrich Nicolai, complete works, letters, documents, vol 6, Memorials and philosophical treatises, part 1, Text, part 2, Commentary, Z GERMAN, 10(3), 2000, pp. 642-644
Authors:
Bergans, N
Stalmans, W
Goldmann, S
Vanstapel, F
Citation: N. Bergans et al., Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401 - Inhibition and inactivation of glycogen phosphorylase by an activated metabolite, DIABETES, 49(9), 2000, pp. 1419-1426
Authors:
Oikonomakos, NG
Tsitsanou, KE
Zographos, SE
Skamnaki, VT
Goldmann, S
Bischoff, H
Citation: Ng. Oikonomakos et al., Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarboxylate, PROTEIN SCI, 8(10), 1999, pp. 1930-1945